Till Örebro universitet

oru.seÖrebro universitets publikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
IgA Nephropathy and the Risk of Primary Infections: A Swedish Population-Based Cohort Study
Örebro universitet, Institutionen för medicinska vetenskaper. Department of Nephrology and Centre for Clinical Research, County Council of Värmland, Central Hospital Karlstad, Karlstad, Sweden.
Region Örebro län. Department of Pediatrics, Örebro University Hospital, Örebro, Sweden; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.ORCID-id: 0000-0003-1024-5602
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Nysäter Health Care Center and Centre for Clinical Research, County Council of Värmland, Värmland County, Sweden; Department of General Practice and General Practice Research Unit (AFE), Institute of Health and Society, University of Oslo, Oslo, Norway.
2025 (Engelska)Ingår i: American Journal of Nephrology, ISSN 0250-8095, E-ISSN 1421-9670, Vol. 56, nr 4, s. 445-456Artikel i tidskrift (Refereegranskat) Published
Abstract [en]

INTRODUCTION: IgA nephropathy is the most common primary kidney disease in the world and has a highly variable clinical presentation. While studies have indicated a link between glomerular disease and infections, large-scale studies on IgA nephropathy are missing.

METHODS: In our study, IgA nephropathy was defined as having a kidney biopsy record 1997-2011 in Sweden. Each IgA nephropathy patient was matched with five reference individuals based on age, sex, calendar year, and county of residence. We excluded individuals with earlier organ transplants, HIV, immunodeficiency, or end-stage kidney disease. Linear and Cox regressions, adjusted for age, sex, education, and diabetes, were performed to analyze total infections and antimicrobial treatments in both patients and reference individuals. Sibling analyses were also performed.

RESULTS: The linear regression analysis revealed a significant association between IgA nephropathy and the overall frequency of infections compared to the general population (β = 0.44; 95% CI: 0.35-0.53) and siblings (β = 0.36; 95% CI: 0.23-0.49). Similarly, antimicrobial prescriptions, especially antibiotics, were more common in IgA nephropathy compared to the general population and to siblings. Cox regression showed an elevated risk of any infection (adjusted hazard ratio [aHR] = 2.00; 95% CI: 1.84-2.18) and sepsis (aHR = 3.18; 95% CI: 2.17-4.65) corresponding to one extra case of sepsis per 63 patients followed for 10 years. The strongest associations were seen for urinary tract infections; ear, nose, and throat infections; and musculoskeletal and gastrointestinal infections.

CONCLUSION: Conclusively, our study demonstrates an increased prevalence of infections and antibiotic prescriptions in IgA nephropathy patients. The increased risk of sepsis warrants clinical awareness and prevention.

Ort, förlag, år, upplaga, sidor
S. Karger, 2025. Vol. 56, nr 4, s. 445-456
Nyckelord [en]
Cohort study, IgA nephropathy, Infections, Sepsis
Nationell ämneskategori
Infektionsmedicin
Identifikatorer
URN: urn:nbn:se:oru:diva-120341DOI: 10.1159/000544753ISI: 001468813400001PubMedID: 40037312Scopus ID: 2-s2.0-105003554695OAI: oai:DiVA.org:oru-120341DiVA, id: diva2:1948849
Forskningsfinansiär
Region Örebro länRegion VärmlandTillgänglig från: 2025-04-01 Skapad: 2025-04-01 Senast uppdaterad: 2026-01-23Bibliografiskt granskad
Ingår i avhandling
1. IgA Nephropathy: Comorbidities and Prognosis - Registry-based Studies
Öppna denna publikation i ny flik eller fönster >>IgA Nephropathy: Comorbidities and Prognosis - Registry-based Studies
2025 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

This thesis investigates the associations between IgA nephropathy (IgAN), a common form of primary glomerulonephritis, and several health outcomes including inflammatory bowel disease (IBD), cancer, infections, and the reliability of biopsy data from the Swedish Renal Registry (SRR).

In a population-based cohort study of 3,963 IgAN patients and 19,978 controls, IgAN was linked to a significantly higher risk of both future and preceding IBD diagnoses. IBD also increased the risk of developing end-stage renal disease (ESRD) in IgAN patients, underscoring the importance of monitoring gastrointestinal comorbidities in this population.

Another cohort study of 3,882 IgAN patients examined the association between IgAN and cancer. An elevated cancer risk was identified, but only in patients who progressed to ESRD, suggesting that the increased cancer incidence is related to advanced kidney disease rather than IgAN itself.

A third study explored the frequency of infections in IgAN patients, revealing a higher incidence of infections and increased antimicrobial use compared to both the general population and sibling controls. The study highlighted a marked risk of sepsis, emphasizing the need for proactive infection prevention in IgAN management.

Finally, validation of biopsy data from the SRR demonstrated a high positive predictive value (95%) for IgAN diagnosis. This reinforces the reliability of the SRR as a valuable tool for future research on IgAN.

Together, these findings contribute to a deeper understanding of IgAN’s broader clinical implications, and the potential risks associated with its progression.

Ort, förlag, år, upplaga, sidor
Örebro: Örebro University, 2025. s. 88
Serie
Örebro Studies in Medicine, ISSN 1652-4063 ; 330
Nyckelord
IgA Nephropathy, Epidemiology, Comorbidities
Nationell ämneskategori
Allmänmedicin
Identifikatorer
urn:nbn:se:oru:diva-120648 (URN)9789175296760 (ISBN)9789175296777 (ISBN)
Disputation
2025-10-17, Örebro universitet, Campus USÖ, Tidefeltsalen, Södra Grev Rosengatan 32, Örebro, 09:00 (Svenska)
Opponent
Handledare
Tillgänglig från: 2025-04-16 Skapad: 2025-04-16 Senast uppdaterad: 2025-09-19Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedScopus

Person

Rehnberg, JohannaLudvigsson, Jonas F.

Sök vidare i DiVA

Av författaren/redaktören
Rehnberg, JohannaLudvigsson, Jonas F.
Av organisationen
Institutionen för medicinska vetenskaperRegion Örebro län
I samma tidskrift
American Journal of Nephrology
Infektionsmedicin

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 112 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf